Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

N/A

BSE: 524669 | NSE: HESTERBIO

Watchlist

NSE BSE

2655.75

05-Jul-2024

Open
High
Low
Previous Close

2513.15
2712.00
2507.55
2513.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

35844
950.33
3379.00
1292.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,044.11
87.10
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,266.41
0.25%
6.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.88
10.69
9.02

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.95
-0.82
-2.38

PAT CAGR (%)

10 Years
5 Years
3 Years

4.24
-8.32
-21.68

P:E (Median)

8 Years
5 Years
3 Years

49.43
52.75
53.97

P:BV (Average)

8 Years
5 Years
3 Years

7.14
6.65
6.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.02
25.89
27.38

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 73.50 66.43 10.64% 73.47 80.34 -8.55% 72.87 60.70 20.05% 65.50 70.77 -7.45%
Expenses 58.77 54.44 7.95% 59.97 68.98 -13.06% 60.46 49.78 21.45% 53.94 51.79 4.15%
EBITDA 14.73 11.99 22.85% 13.50 11.37 18.73% 12.41 10.92 13.64% 11.57 18.99 -39.07%
EBIDTM 20.04% 18.05% 18.37% 14.15% 17.04% 17.99% 17.66% 26.83%
Other Income 1.35 1.22 10.66% 1.06 0.86 23.26% 1.20 0.95 26.32% 0.98 0.96 2.08%
Interest 1.40 1.48 -5.41% 1.13 0.94 20.21% 1.31 0.35 274.29% 1.37 3.14 -56.37%
Depreciation 2.19 2.58 -15.12% 2.12 2.55 -16.86% 2.08 2.62 -20.61% 2.57 2.44 5.33%
PBT 12.48 9.16 36.24% 11.30 8.73 29.44% 10.22 8.90 14.83% 8.61 14.38 -40.13%
Tax 3.15 2.38 32.35% 2.87 2.26 26.99% 2.79 2.64 5.68% 2.14 3.65 -41.37%
PAT 9.34 6.78 37.76% 8.43 6.47 30.29% 7.43 6.26 18.69% 6.47 10.73 -39.70%
PATM 12.70% 10.21% 11.48% 8.05% 10.20% 10.32% 9.88% 15.16%
EPS 10.98 7.98 37.59% 9.92 7.61 30.35% 8.74 7.37 18.59% 7.62 12.62 -39.62%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 83.69 70.45 18.79% 82.27 87.85 -6.35% 79.25 67.30 17.76% 66.98 74.94 -10.62%
Expenses 64.53 57.24 12.74% 64.62 73.49 -12.07% 63.33 55.62 13.86% 56.83 56.19 1.14%
EBITDA 19.16 13.22 44.93% 17.65 14.36 22.91% 15.92 11.68 36.30% 10.16 18.76 -45.84%
EBIDTM 22.89% 18.76% 21.45% 16.35% 20.09% 17.35% 15.16% 25.03%
Other Income 1.84 4.36 -57.80% 1.23 1.15 6.96% 4.15 3.19 30.09% 0.99 4.39 -77.45%
Interest 5.89 8.07 -27.01% 5.01 2.57 94.94% 6.94 1.37 406.57% 2.19 3.89 -43.70%
Depreciation 4.20 4.28 -1.87% 4.13 5.40 -23.52% 3.74 5.37 -30.35% 3.75 5.24 -28.44%
PBT 10.91 5.21 109.40% 9.73 7.54 29.05% 9.39 8.12 15.64% 5.20 14.02 -62.91%
Tax 3.48 2.72 27.94% 3.11 2.20 41.36% 3.47 2.71 28.04% 2.39 3.84 -37.76%
PAT 7.44 2.49 198.80% 6.63 5.34 24.16% 5.91 5.42 9.04% 2.81 10.18 -72.40%
PATM 8.88% 3.54% 8.05% 6.08% 7.46% 8.05% 4.20% 13.58%
EPS 9.64 4.80 100.83% 7.45 6.90 7.97% 5.82 5.33 9.19% 4.68 13.15 -64.41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 285.34 285.15 254.00 219.35 208.48 169.43 171.19 134.79 123.28 100.89 90.04 Net Sales Growth 2.55% 12.26% 15.80% 5.21% 23.05% -1.03% 27.00% 9.34% 22.19% 12.05% Cost Of Goods Sold 92.46 99.64 79.88 63.84 53.39 29.24 29.21 23.31 29.89 19.75 25.29 Gross Profit 192.88 185.51 174.12 155.51 155.08 140.19 141.97 111.47 93.39 81.14 64.75 GP Margin 67.60% 65.06% 68.55% 70.90% 74.39% 82.74% 82.93% 82.70% 75.75% 80.42% 71.91% Total Expenditure 233.14 238.30 199.32 158.78 136.48 116.70 103.42 85.19 82.21 67.50 63.87 Power & Fuel Cost - 12.34 9.95 8.74 6.93 7.29 7.08 5.84 5.31 5.81 4.70 % Of Sales - 4.33% 3.92% 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% 5.76% 5.22% Employee Cost - 56.72 47.92 39.12 33.45 37.16 26.74 22.29 18.32 15.44 12.24 % Of Sales - 19.89% 18.87% 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% 15.30% 13.59% Manufacturing Exp. - 15.20 10.54 10.17 10.79 11.31 10.95 9.24 6.97 7.85 4.94 % Of Sales - 5.33% 4.15% 4.64% 5.18% 6.68% 6.40% 6.86% 5.65% 7.78% 5.49% General & Admin Exp. - 24.92 21.60 14.50 13.24 16.34 11.77 12.92 11.35 10.23 8.65 % Of Sales - 8.74% 8.50% 6.61% 6.35% 9.64% 6.88% 9.59% 9.21% 10.14% 9.61% Selling & Distn. Exp. - 24.63 24.68 17.16 13.68 11.42 16.02 9.09 8.15 6.77 7.14 % Of Sales - 8.64% 9.72% 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% 6.71% 7.93% Miscellaneous Exp. - 4.86 4.76 5.26 5.00 3.95 1.65 2.50 2.22 1.64 7.14 % Of Sales - 1.70% 1.87% 2.40% 2.40% 2.33% 0.96% 1.85% 1.80% 1.63% 1.00% EBITDA 52.21 46.85 54.68 60.57 72.00 52.73 67.77 49.60 41.07 33.39 26.17 EBITDA Margin 18.30% 16.43% 21.53% 27.61% 34.54% 31.12% 39.59% 36.80% 33.31% 33.10% 29.06% Other Income 4.59 4.75 5.53 4.66 1.65 2.93 3.10 1.88 0.73 0.87 0.33 Interest 5.21 5.09 6.50 2.47 3.95 5.03 3.54 2.32 3.21 3.69 4.41 Depreciation 8.96 9.78 9.79 9.50 9.63 9.38 7.57 5.45 5.51 5.73 5.29 PBT 42.61 36.73 43.92 53.26 60.06 41.23 59.75 43.71 33.09 24.85 16.80 Tax 10.95 9.57 11.58 13.74 14.88 10.01 15.90 13.15 8.15 5.63 4.87 Tax Rate 25.70% 26.05% 26.37% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% 22.66% 25.04% PAT 31.67 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 PAT before Minority Interest 31.67 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.10% 9.52% 12.73% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% 19.05% 16.19% PAT Growth 4.73% -16.02% -18.17% -0.95% 27.80% -28.80% 43.49% 22.53% 29.76% 31.82% EPS 37.26 31.95 38.05 46.49 46.94 36.73 51.59 35.95 29.34 22.61 17.15

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 312.19 304.55 266.09 235.01 214.33 183.27 178.07 135.94 123.11 100.89 90.64 Net Sales Growth 3.88% 14.45% 13.22% 9.65% 16.95% 2.92% 30.99% 10.42% 22.02% 11.31% Cost Of Goods Sold 90.13 95.88 77.49 64.85 50.23 27.98 28.47 23.31 28.45 19.75 25.32 Gross Profit 222.06 208.67 188.60 170.15 164.11 155.29 149.60 112.63 94.65 81.14 65.32 GP Margin 71.13% 68.52% 70.88% 72.40% 76.57% 84.73% 84.01% 82.85% 76.88% 80.42% 72.07% Total Expenditure 249.31 251.38 215.69 175.02 145.67 127.87 110.03 88.68 82.09 67.50 65.90 Power & Fuel Cost - 15.30 12.74 10.28 7.57 8.13 7.83 6.37 5.59 5.81 4.77 % Of Sales - 5.02% 4.79% 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% 5.76% 5.26% Employee Cost - 64.13 56.02 45.33 38.92 40.65 28.93 23.24 18.32 15.44 12.32 % Of Sales - 21.06% 21.05% 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% 15.30% 13.59% Manufacturing Exp. - 17.13 12.67 11.51 11.60 11.98 11.34 9.45 7.06 7.85 5.25 % Of Sales - 5.62% 4.76% 4.90% 5.41% 6.54% 6.37% 6.95% 5.73% 7.78% 5.79% General & Admin Exp. - 27.17 24.89 19.20 15.29 13.47 13.72 13.81 11.47 10.23 8.90 % Of Sales - 8.92% 9.35% 8.17% 7.13% 7.35% 7.70% 10.16% 9.32% 10.14% 9.82% Selling & Distn. Exp. - 25.60 26.34 17.31 14.73 18.97 16.77 9.11 8.15 6.77 7.14 % Of Sales - 8.41% 9.90% 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% 6.71% 7.88% Miscellaneous Exp. - 6.18 5.54 6.53 7.34 6.69 2.98 3.40 3.05 1.64 7.14 % Of Sales - 2.03% 2.08% 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% 1.63% 2.43% EBITDA 62.89 53.17 50.40 59.99 68.66 55.40 68.04 47.26 41.02 33.39 24.74 EBITDA Margin 20.14% 17.46% 18.94% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% 33.10% 27.29% Other Income 8.21 11.13 15.36 13.74 4.68 6.37 7.21 2.55 0.42 0.88 0.34 Interest 20.03 19.77 9.32 4.06 6.60 7.37 6.63 4.04 3.50 3.72 4.83 Depreciation 15.82 17.17 20.70 16.58 13.31 13.07 11.76 9.66 7.00 5.75 5.92 PBT 35.23 27.34 35.74 53.08 53.42 41.33 56.86 36.12 30.93 24.81 14.33 Tax 12.45 10.79 12.12 14.02 15.40 10.32 16.16 13.05 8.15 5.63 4.82 Tax Rate 35.34% 39.47% 33.91% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% 22.69% 28.39% PAT 22.79 18.89 26.63 39.32 34.43 29.17 41.56 25.62 23.55 19.19 12.47 PAT before Minority Interest 19.97 21.17 28.04 39.48 34.70 31.00 40.69 23.07 22.79 19.18 12.17 Minority Interest -2.82 -2.28 -1.41 -0.16 -0.27 -1.83 0.87 2.55 0.76 0.01 0.30 PAT Margin 7.30% 6.20% 10.01% 16.73% 16.06% 15.92% 23.34% 18.85% 19.13% 19.02% 13.76% PAT Growth -2.73% -29.06% -32.27% 14.20% 18.03% -29.81% 62.22% 8.79% 22.72% 53.89% EPS 26.81 22.22 31.33 46.26 40.51 34.32 48.89 30.14 27.71 22.58 14.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 312.71 292.38 268.43 237.58 203.08 179.44 146.08 122.09 100.32 84.25 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 304.20 283.88 259.93 229.07 194.57 170.93 137.57 113.58 91.81 75.74 Non-Current Liabilities 139.11 116.96 81.17 9.79 15.89 21.51 21.98 22.36 21.05 21.29 Secured Loans 79.07 83.40 73.25 2.68 7.45 11.37 14.61 18.66 12.87 14.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 Long Term Provisions 2.26 1.72 1.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 97.72 136.47 74.84 34.65 58.22 39.30 42.43 33.99 37.45 34.87 Trade Payables 30.12 28.71 11.03 14.03 13.61 8.05 7.85 7.47 5.84 4.63 Other Current Liabilities 35.14 46.59 29.34 15.11 12.37 10.05 9.33 7.82 8.55 6.22 Short Term Borrowings 29.79 57.34 33.29 1.71 31.80 20.94 24.19 17.51 21.04 20.08 Short Term Provisions 2.67 3.83 1.18 3.81 0.44 0.26 1.06 1.18 2.02 3.95 Total Liabilities 549.54 545.81 424.44 282.02 277.19 240.25 210.49 178.44 158.82 140.41 Net Block 103.46 108.22 84.31 86.69 96.76 100.81 66.74 60.85 61.57 56.53 Gross Block 203.62 199.00 171.17 164.64 166.61 161.97 120.89 109.55 105.07 94.40 Accumulated Depreciation 100.16 90.78 86.86 77.95 69.85 61.02 54.15 48.70 43.50 37.87 Non Current Assets 345.13 329.77 257.97 142.41 154.01 140.84 121.36 103.63 91.64 87.65 Capital Work in Progress 171.40 148.61 81.91 3.72 0.87 0.42 30.47 21.29 10.47 14.27 Non Current Investment 64.69 64.69 64.69 43.88 40.67 28.22 14.48 8.60 8.67 8.88 Long Term Loans & Adv. 4.85 6.83 24.20 5.32 11.83 9.81 9.59 12.41 10.93 7.97 Other Non Current Assets 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 Current Assets 204.41 216.05 166.47 139.61 123.18 99.40 89.13 74.81 67.18 52.77 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 68.53 79.22 70.73 57.01 60.43 48.50 38.70 33.07 33.62 29.11 Sundry Debtors 85.78 82.36 56.92 45.55 44.76 32.67 31.94 26.71 26.24 17.76 Cash & Bank 4.96 5.96 1.98 1.24 5.19 2.49 11.95 11.48 5.26 4.38 Other Current Assets 45.14 5.45 2.83 6.30 12.80 15.74 6.54 3.56 2.07 1.51 Short Term Loans & Adv. 39.78 43.06 34.01 29.50 11.84 12.95 5.69 3.30 2.07 1.51 Net Current Assets 106.69 79.58 91.64 104.96 64.96 60.10 46.70 40.82 29.73 17.89 Total Assets 549.54 545.82 424.44 282.02 277.19 240.24 210.49 178.44 158.82 140.42

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 291.79 279.73 259.99 228.31 201.07 177.46 140.63 121.95 101.71 84.92 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 283.29 271.22 251.48 219.80 192.56 168.95 132.13 113.44 93.20 76.41 Non-Current Liabilities 253.69 232.72 197.87 113.72 96.64 69.64 44.41 48.32 41.28 37.66 Secured Loans 181.77 184.85 164.54 82.84 76.48 58.35 36.54 44.62 33.09 30.89 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 Long Term Provisions 2.53 1.93 1.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 105.78 148.70 96.90 61.37 83.46 48.66 54.63 38.01 38.20 35.01 Trade Payables 26.44 29.98 18.02 28.09 20.02 8.75 7.90 7.47 5.84 4.63 Other Current Liabilities 44.78 55.96 42.81 22.52 30.44 17.15 20.26 11.04 9.30 6.35 Short Term Borrowings 31.35 58.86 34.84 3.28 32.54 22.50 25.41 18.32 21.04 20.08 Short Term Provisions 3.22 3.90 1.22 7.48 0.46 0.26 1.07 1.18 2.02 3.95 Total Liabilities 662.34 669.97 562.17 411.05 386.59 299.46 244.04 212.88 185.84 160.46 Net Block 240.11 259.37 237.17 132.76 142.54 144.82 110.22 102.62 64.63 59.60 Gross Block 382.04 385.80 348.16 228.12 226.04 215.94 170.22 152.95 108.25 97.57 Accumulated Depreciation 141.93 126.43 110.99 95.36 83.50 70.98 60.00 50.33 43.62 37.97 Non Current Assets 447.73 442.37 367.40 249.54 227.29 157.80 145.59 132.91 111.63 100.45 Capital Work in Progress 171.40 148.61 81.91 109.17 74.15 7.05 31.81 21.29 36.46 32.60 Non Current Investment 29.93 25.30 21.24 0.00 0.00 0.00 0.00 0.00 0.07 0.28 Long Term Loans & Adv. 5.55 7.67 24.22 4.82 6.74 4.34 3.48 8.52 10.47 7.97 Other Non Current Assets 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 Current Assets 214.62 227.59 194.76 161.50 159.31 141.66 98.45 79.97 74.20 60.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 75.58 84.81 75.38 62.22 63.97 50.79 39.76 33.41 33.62 29.11 Sundry Debtors 78.64 79.63 55.28 49.21 58.44 32.87 32.29 26.53 26.24 17.76 Cash & Bank 15.30 14.82 25.20 21.27 23.53 41.05 13.39 11.48 5.28 6.58 Other Current Assets 45.08 6.02 5.20 2.56 13.37 16.95 13.01 8.54 9.05 6.55 Short Term Loans & Adv. 39.27 42.31 33.70 26.24 8.19 11.32 8.95 5.06 2.49 6.55 Net Current Assets 108.83 78.90 97.87 100.14 75.84 92.99 43.82 41.95 36.00 25.00 Total Assets 662.35 669.96 562.16 411.04 386.60 299.46 244.04 212.88 185.83 160.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 42.81 33.36 15.90 41.10 25.82 36.19 32.28 27.55 18.64 20.37 PBT 36.73 43.92 53.26 54.78 41.23 59.75 43.71 33.09 24.85 18.81 Adjustment 13.32 14.55 11.70 19.61 12.25 8.50 7.34 8.74 9.31 7.23 Changes in Working Capital 3.79 -17.05 -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 -9.54 -0.23 Cash after chg. in Working capital 53.84 41.43 32.34 54.59 37.17 51.78 41.67 34.61 24.62 25.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.03 -8.06 -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 -5.97 -5.45 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -20.63 -71.96 -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 -5.68 -12.02 Net Fixed Assets -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 Net Investments 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 Others 6.78 22.57 -5.05 0.37 -3.79 0.07 0.08 -0.26 0.98 5.27 Cash from Financing Activity -24.07 41.38 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 -11.92 -5.21 Net Cash Inflow / Outflow -1.89 2.77 0.28 -3.95 3.10 -8.80 -0.28 6.46 1.04 3.13 Opening Cash & Equivalents 4.30 1.53 1.24 5.19 2.09 10.89 11.17 4.71 3.92 0.69 Closing Cash & Equivalent 2.41 4.30 1.53 1.24 5.19 2.09 10.89 11.17 4.96 3.92

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 48.13 23.60 8.71 58.05 36.77 46.71 38.02 34.80 18.85 19.76 PBT 31.95 40.15 53.50 50.10 41.33 56.86 36.12 30.93 24.81 18.20 Adjustment 24.22 12.39 11.10 20.34 20.13 17.92 13.63 10.86 9.38 7.34 Changes in Working Capital 3.63 -20.84 -38.78 1.54 -13.75 -12.26 -2.31 0.11 -9.37 -0.33 Cash after chg. in Working capital 59.80 31.70 25.82 71.99 47.71 62.52 47.44 41.90 24.82 25.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.67 -8.11 -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 -5.97 -5.45 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 Cash From Investing Activity -22.65 -77.00 -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 -13.30 -21.21 Net Fixed Assets -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 Net Investments 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 Others 4.76 17.53 -11.06 -34.28 -56.93 3.04 0.57 -14.96 -6.64 -3.92 Cash from Financing Activity -26.05 41.76 111.54 -18.22 18.74 2.65 -11.08 1.83 -6.68 6.76 Net Cash Inflow / Outflow -0.56 -11.64 3.66 1.46 -18.96 27.63 1.12 6.45 -1.14 5.31 Opening Cash & Equivalents 13.16 24.75 21.27 23.53 40.65 12.33 11.18 4.73 6.12 0.82 Closing Cash & Equivalent 12.75 13.16 24.75 21.27 23.53 40.65 12.33 11.18 4.99 6.12

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 367.59 343.70 315.54 279.28 238.72 210.93 171.72 143.52 117.93 101.13 ROA 4.96% 6.67% 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% 12.85% 10.82% ROE 8.98% 11.53% 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% 20.83% 18.00% ROCE 9.26% 11.91% 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% 21.79% 20.29% Fixed Asset Turnover 1.42 1.38 1.32 1.26 1.03 1.21 1.17 1.17 1.03 1.06 Receivable days 107.52 99.32 84.52 79.06 83.41 68.88 79.13 76.95 77.96 63.99 Inventory Days 94.48 106.93 105.37 102.81 117.33 92.96 96.84 96.91 111.14 127.96 Payable days 107.75 90.79 71.61 94.44 36.28 28.05 36.46 33.72 29.57 27.98 Cash Conversion Cycle 94.25 115.46 118.28 87.43 164.47 133.79 139.51 140.15 159.53 163.98 Total Debt/Equity 0.43 0.56 0.45 0.07 0.24 0.21 0.29 0.32 0.39 0.44 Interest Cover 8.21 7.76 22.58 14.88 9.19 17.87 19.88 11.31 7.74 5.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 343.00 328.82 305.61 268.38 236.36 208.61 165.32 143.35 119.56 96.86 ROA 3.18% 4.55% 8.11% 8.70% 9.04% 14.97% 10.10% 11.43% 11.08% 8.06% ROE 7.41% 10.39% 16.17% 16.16% 16.38% 25.59% 17.57% 20.38% 20.56% 15.46% ROCE 9.59% 9.60% 14.12% 17.33% 16.53% 26.64% 20.20% 19.75% 18.98% 16.53% Fixed Asset Turnover 0.79 0.73 0.82 0.95 0.83 0.92 0.84 0.96 1.00 1.01 Receivable days 94.77 91.87 80.50 91.49 90.92 66.77 78.70 76.80 77.96 63.83 Inventory Days 96.04 109.08 106.00 107.25 114.27 92.80 97.89 97.55 111.14 127.14 Payable days 107.38 113.04 129.73 174.82 42.10 27.25 33.70 33.48 29.56 28.17 Cash Conversion Cycle 83.43 87.91 56.77 23.92 163.09 132.33 142.89 140.87 159.54 162.80 Total Debt/Equity 0.82 0.96 0.86 0.46 0.60 0.51 0.49 0.54 0.58 0.71 Interest Cover 2.62 5.31 14.16 8.59 6.61 9.57 9.95 9.84 7.67 4.52

Top Investors:

kuntal hasmukhlal shah

darshna dinesh kapadia

jagrut prataprai gandhi

manish prataprai gandhi

sandeep shantilal gala

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hester Biosciences - Quarterly Results
28th Oct 2024, 12:27 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback